dimethyl fumarate

FDA Approves New MS Drug

FDA Approves New MS Drug

The Food and Drug Administration has approved a new oral drug for the treatment of multiple sclerosis (MS). Manufactured by the Cambridge, Massachusetts-based Biogen Idec…